Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
Merrick et al. have reported long-term follow-up data on 42 consecutively treated younger men, all ≤ 50 years of age, who received permanent seed implantation between 1997 and 2004 as primary treatment for localized prostate cancer. None of the patients underwent seminal vesicle biopsy or pathologic lymph node staging.
Filed under: Management, Treatment | Tagged: brachytherapy younger men | Leave a Comment »
Dietary factors are believed to influence the development and progression of prostate cancer. Data has now been published to show that “flaxseed is … associated with biological alterations that may be protective for prostate cancer.”
Filed under: Management, Prevention, Risk | Leave a Comment »
A report just published in the Journal of Cancer Education seems to epitomize two of the problems within the world of prostate cancer advocacy: (a) a lack of consensus about what is really important and (b) our own failure to act promptly and decisively when called upon to do so!
Filed under: Living with Prostate Cancer | 2 Comments »
There are three reports in our first daily report for 2009, dealing with issues as varied as genetic profiling for prostate cancer risk, the relative merits of LRP and RALP, and the management of geriatric prostate cancer patients who are on long-term hormone therapy.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: gene, geriatric, hormone, LRP, RALP, risk, SNPs | 10 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site